Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03865589 · ClinicalTrials.gov registry record · NA
Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome
A NA study of Stem Cell Transplant Complications and Bone Marrow Transplant Complications, sponsored by Children's Mercy Hospital Kansas City.
- Active
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 7
- Study locations
NCT03865589: Active NA study of Stem Cell Transplant Complications and Bone Marrow Transplant Complications, sponsored by Children's Mercy Hospital Kansas City.
NCT03865589 is a NA study of Stem Cell Transplant Complications and Bone Marrow Transplant Complications that is active but no longer recruiting, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 250 participants, above the 169-participant average among 15 other Stem Cell Transplant Complications trials with a reported enrollment target (48% higher). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03865589, a NA study of Stem Cell Transplant Complications and Bone Marrow Transplant Complications, is active but no longer recruiting, sponsored by Children's Mercy Hospital Kansas City.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 7
- Study locations
Study Summary
To perform an receiver operating characteristic (ROC) analysis, define a threshold and quantify the sensitivity and specificity of US SWE for risk stratification of patients into three categories as defined by the European Bone Marrow Transplant (EBMT) adult and pediatric criteria: no sinusoidal obstruction syndrome (SOS), mild to moderate SOS, and severe to very severe SOS. Secondarily, the investigators would also like to quantify the temporal relationship between US SWE changes and SOS diagnosis according to various clinical criteria (Modified Seattle, Baltimore, EBMT consortium).
Primary Outcome
To define a threshold and quantify the sensitivity and specificity of US SWE for risk stratification of patients into three categories as defined by the EBMTC adult and pediatric criteria: no SOS, mild to moderate SOS, and severe to very severe SOS
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Ultrasound Elastography
Study Locations (7)
Ohio
- University Hospitals Cleveland Medical Center - Cleveland
- Nationwide Children's Hospital - Columbus
California
- University of California, San Francisco - San Francisco
Massachusetts
- Dana-Farber Cancer Institute - Boston
Missouri
- Children's Mercy - Kansas City
North Carolina
- Duke University - Durham
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What the registry record for NCT03865589 still lists
NCT03865589 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 169-participant average among 15 other Stem Cell Transplant Complications trials with a reported enrollment target (48% higher).
The record links to 4 conditions, with Stem Cell Transplant Complications appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound Elastography is the first listed.
NCT03865589 lists 7 locations in 6 states (Ohio, California, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT03865589 about?
NCT03865589 is a clinical study titled "Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome". To perform an receiver operating characteristic (ROC) analysis, define a threshold and quantify the sensitivity and specificity of US SWE for risk stratification of patients into three categories as defined by the European Bone Marrow Transplant (EBMT) adult and pediatric criteria: no sinusoidal obs...
What is the current status of trial NCT03865589?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2019-04-01. Estimated completion is 2027-06-30.
What conditions does trial NCT03865589 study?
This clinical trial studies the following conditions: Stem Cell Transplant Complications, Bone Marrow Transplant Complications, Sinusoidal Obstruction Syndrome, Veno Occlusive Disease, Hepatic.
What interventions are being tested in trial NCT03865589?
The interventions under investigation include: Ultrasound Elastography (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03865589?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03865589 being conducted?
This trial has 7 study locations across California, Massachusetts, Missouri, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stem Cell Transplant Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03865589's enrollment target sits among peer trials
250 5th of 15 higher than 11 of 15 other Stem Cell Transplant Complications trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stem Cell Transplant Complications trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors
RECRUITING · NA
-
Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
RECRUITING · NA
-
Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients
RECRUITING · NA
-
Horizons Chronic Graft-Versus-Host-Disease Study
ACTIVE NOT RECRUITING · NA
-
Multidisciplinary Intervention In Chronic GVHD
ACTIVE NOT RECRUITING · NA
-
A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI